A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers
Phase IV Prospective, Multi-Center, Randomized, Single-Blind, Active and Standard Care-Controlled Study of DermaPure™ in Patients With Hard to Heal Chronic, Neuropathic Diabetic Foot Ulcers With Crossover Design for Standard Care Arm
Sponsor: TRx Wound Care Limited
This PHASE4 trial investigates Diabetic Foot Ulcers and is currently ongoing. TRx Wound Care Limited leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Feb 2018 [monthly]
Recruiting PHASE4
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- TRx Wound Care Limited
For direct contact, visit the study record on ClinicalTrials.gov .